NYLXS - Free Software Events

Fri Nov 22 00:02:31 2024

EVENTS

FREE
SOFTWARE
INSTITUTE

POLITICS

JOBS

MEMBERS'
CORNER

MAILING
LIST

NYLXS Members have a lot to say and share but we don't keep many secrets. Join the Hangout Mailing List and say your peice.

DATE 2020-05-01

HANGOUT

2024-11-22 | 2024-10-22 | 2024-09-22 | 2024-08-22 | 2024-07-22 | 2024-06-22 | 2024-05-22 | 2024-04-22 | 2024-03-22 | 2024-02-22 | 2024-01-22 | 2023-12-22 | 2023-11-22 | 2023-10-22 | 2023-09-22 | 2023-08-22 | 2023-07-22 | 2023-06-22 | 2023-05-22 | 2023-04-22 | 2023-03-22 | 2023-02-22 | 2023-01-22 | 2022-12-22 | 2022-11-22 | 2022-10-22 | 2022-09-22 | 2022-08-22 | 2022-07-22 | 2022-06-22 | 2022-05-22 | 2022-04-22 | 2022-03-22 | 2022-02-22 | 2022-01-22 | 2021-12-22 | 2021-11-22 | 2021-10-22 | 2021-09-22 | 2021-08-22 | 2021-07-22 | 2021-06-22 | 2021-05-22 | 2021-04-22 | 2021-03-22 | 2021-02-22 | 2021-01-22 | 2020-12-22 | 2020-11-22 | 2020-10-22 | 2020-09-22 | 2020-08-22 | 2020-07-22 | 2020-06-22 | 2020-05-22 | 2020-04-22 | 2020-03-22 | 2020-02-22 | 2020-01-22 | 2019-12-22 | 2019-11-22 | 2019-10-22 | 2019-09-22 | 2019-08-22 | 2019-07-22 | 2019-06-22 | 2019-05-22 | 2019-04-22 | 2019-03-22 | 2019-02-22 | 2019-01-22 | 2018-12-22 | 2018-11-22 | 2018-10-22 | 2018-09-22 | 2018-08-22 | 2018-07-22 | 2018-06-22 | 2018-05-22 | 2018-04-22 | 2018-03-22 | 2018-02-22 | 2018-01-22 | 2017-12-22 | 2017-11-22 | 2017-10-22 | 2017-09-22 | 2017-08-22 | 2017-07-22 | 2017-06-22 | 2017-05-22 | 2017-04-22 | 2017-03-22 | 2017-02-22 | 2017-01-22 | 2016-12-22 | 2016-11-22 | 2016-10-22 | 2016-09-22 | 2016-08-22 | 2016-07-22 | 2016-06-22 | 2016-05-22 | 2016-04-22 | 2016-03-22 | 2016-02-22 | 2016-01-22 | 2015-12-22 | 2015-11-22 | 2015-10-22 | 2015-09-22 | 2015-08-22 | 2015-07-22 | 2015-06-22 | 2015-05-22 | 2015-04-22 | 2015-03-22 | 2015-02-22 | 2015-01-22 | 2014-12-22 | 2014-11-22 | 2014-10-22 | 2014-09-22 | 2014-08-22 | 2014-07-22 | 2014-06-22 | 2014-05-22 | 2014-04-22 | 2014-03-22 | 2014-02-22 | 2014-01-22 | 2013-12-22 | 2013-11-22 | 2013-10-22 | 2013-09-22 | 2013-08-22 | 2013-07-22 | 2013-06-22 | 2013-05-22 | 2013-04-22 | 2013-03-22 | 2013-02-22 | 2013-01-22 | 2012-12-22 | 2012-11-22 | 2012-10-22 | 2012-09-22 | 2012-08-22 | 2012-07-22 | 2012-06-22 | 2012-05-22 | 2012-04-22 | 2012-03-22 | 2012-02-22 | 2012-01-22 | 2011-12-22 | 2011-11-22 | 2011-10-22 | 2011-09-22 | 2011-08-22 | 2011-07-22 | 2011-06-22 | 2011-05-22 | 2011-04-22 | 2011-03-22 | 2011-02-22 | 2011-01-22 | 2010-12-22 | 2010-11-22 | 2010-10-22 | 2010-09-22 | 2010-08-22 | 2010-07-22 | 2010-06-22 | 2010-05-22 | 2010-04-22 | 2010-03-22 | 2010-02-22 | 2010-01-22 | 2009-12-22 | 2009-11-22 | 2009-10-22 | 2009-09-22 | 2009-08-22 | 2009-07-22 | 2009-06-22 | 2009-05-22 | 2009-04-22 | 2009-03-22 | 2009-02-22 | 2009-01-22 | 2008-12-22 | 2008-11-22 | 2008-10-22 | 2008-09-22 | 2008-08-22 | 2008-07-22 | 2008-06-22 | 2008-05-22 | 2008-04-22 | 2008-03-22 | 2008-02-22 | 2008-01-22 | 2007-12-22 | 2007-11-22 | 2007-10-22 | 2007-09-22 | 2007-08-22 | 2007-07-22 | 2007-06-22 | 2007-05-22 | 2007-04-22 | 2007-03-22 | 2007-02-22 | 2007-01-22 | 2006-12-22 | 2006-11-22 | 2006-10-22 | 2006-09-22 | 2006-08-22 | 2006-07-22 | 2006-06-22 | 2006-05-22 | 2006-04-22 | 2006-03-22 | 2006-02-22 | 2006-01-22 | 2005-12-22 | 2005-11-22 | 2005-10-22 | 2005-09-22 | 2005-08-22 | 2005-07-22 | 2005-06-22 | 2005-05-22 | 2005-04-22 | 2005-03-22 | 2005-02-22 | 2005-01-22 | 2004-12-22 | 2004-11-22 | 2004-10-22 | 2004-09-22 | 2004-08-22 | 2004-07-22 | 2004-06-22 | 2004-05-22 | 2004-04-22 | 2004-03-22 | 2004-02-22 | 2004-01-22 | 2003-12-22 | 2003-11-22 | 2003-10-22 | 2003-09-22 | 2003-08-22 | 2003-07-22 | 2003-06-22 | 2003-05-22 | 2003-04-22 | 2003-03-22 | 2003-02-22 | 2003-01-22 | 2002-12-22 | 2002-11-22 | 2002-10-22 | 2002-09-22 | 2002-08-22 | 2002-07-22 | 2002-06-22 | 2002-05-22 | 2002-04-22 | 2002-03-22 | 2002-02-22 | 2002-01-22 | 2001-12-22 | 2001-11-22 | 2001-10-22 | 2001-09-22 | 2001-08-22 | 2001-07-22 | 2001-06-22 | 2001-05-22 | 2001-04-22 | 2001-03-22 | 2001-02-22 | 2001-01-22 | 2000-12-22 | 2000-11-22 | 2000-10-22 | 2000-09-22 | 2000-08-22 | 2000-07-22 | 2000-06-22 | 2000-05-22 | 2000-04-22 | 2000-03-22 | 2000-02-22 | 2000-01-22 | 1999-12-22

Key: Value:

MESSAGE

DATE

2020-05-26

FROM

From: "Pharmacy Times Continuing Education - PTCE"

SUBJECT

Subject: [Hangout - NYLXS] COVID-19 Live Webinar Series Part 2 takes place

From hangout-bounces-at-nylxs.com Tue May 26 20:55:23 2020
Return-Path:
X-Original-To: archive-at-mrbrklyn.com
Delivered-To: archive-at-mrbrklyn.com
Received: from www2.mrbrklyn.com (www2.mrbrklyn.com [96.57.23.82])
by mrbrklyn.com (Postfix) with ESMTP id 59FCA163F7A;
Tue, 26 May 2020 20:54:58 -0400 (EDT)
X-Original-To: hangout-at-www2.mrbrklyn.com
Delivered-To: hangout-at-www2.mrbrklyn.com
Received: by mrbrklyn.com (Postfix, from userid 1000)
id 73715163F77; Tue, 26 May 2020 20:54:56 -0400 (EDT)
Resent-From: Ruben Safir
Resent-Date: Tue, 26 May 2020 20:54:56 -0400
Resent-Message-ID: <20200527005456.GA1196-at-www2.mrbrklyn.com>
Resent-To: hangout-at-mrbrklyn.com
X-Original-To: ruben-at-mrbrklyn.com
Delivered-To: ruben-at-mrbrklyn.com
Received: from mx33.b.outbound.createsend.com (mx33.b.outbound.createsend.com
[27.126.146.33]) by mrbrklyn.com (Postfix) with ESMTP id 5F31516115C
for ; Tue, 26 May 2020 20:01:59 -0400 (EDT)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cm; d=pharmacytimes.org;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
i=ptce-at-pharmacytimes.org; bh=6kONKBb4fwjLvK7S0lxaMT3izu0=;
b=WiAu0Z6wFUqDJJ9dl4KxCH/yAHL1ktfB/8NdISyFUssCHvu0/Wabk+SwxIoCr/PD2c4aR7fcFbeA
eqHf5iwfSxvC9nBp8U1R+JTZs/yPHuatHApGOuAGibcB3nD3Jj1ncelaFWIGR0bqo6XybNVKvUxW
89j3tkKmPeI5sZ6wmM0=
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=cs2013; d=cmail2.com;
h=Subject:From:To:Reply-To:Date:MIME-Version:Content-Type:List-Unsubscribe:Message-ID;
bh=6kONKBb4fwjLvK7S0lxaMT3izu0=;
b=ek9EJQBY6txHQpWEhZbpJ5H3ROYSO9DkrwG6jMeqmWMDq68mwT2+P5HUMX7nZy2qMkSi9M1psa45
uEwyGH1bB9J3t/K/ILpdEI8JHAUFp7XiYwDTo3BYTFpko6XFCtCudzJsTqVqUyBM4xds/5U91Wmz
boMATd3u0tHL0s1iSYs=
From: "Pharmacy Times Continuing Education - PTCE"
To: "Ruben Safir"
Date: Wed, 27 May 2020 10:01:40 +1000
MIME-Version: 1.0
X-Mailer: Create Send
X-Complaints-To: abuse-at-cmail20.com
X-Feedback-ID: CA1-j-qtukic:LI1-j-ekrikh:CL1-j-jruiiu:createSEND
Message-ID:
Subject: [Hangout - NYLXS] COVID-19 Live Webinar Series Part 2 takes place
this weekend!
X-BeenThere: hangout-at-nylxs.com
X-Mailman-Version: 2.1.30rc1
Precedence: list
List-Id: NYLXS Tech Talk and Politics
List-Unsubscribe: ,

List-Archive:
List-Post:
List-Help:
List-Subscribe: ,

Reply-To: ptce-at-pharmacytimes.org
Content-Type: multipart/mixed; boundary="===============1122153626=="
Errors-To: hangout-bounces-at-nylxs.com
Sender: "Hangout"

--===============1122153626==
Content-Type: multipart/alternative;
boundary="_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_"; charset=utf-8

--_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qtukic-ttqvtdkr-p/

Part 2 of a 5-Part Live Webinar Series

Existing and Investigational Pharmacotherapy for COVID-19

0.75 Live Credit

Sunday, May 31 at 12:00 PM ET

This second webinar in the 5-part series will delve into the pharmacist=E2=
=80=99s responsibility to report fraudulent products and potential drug s=
hortages. Investigational pharmacotherapy information for the care of pat=
ients with confirmed COVID-19 will be presented.

Faculty Presenter

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Clinical Professor

Clinical Specialist, Infectious Diseases

Director, PGY2 Residency in Infectious Diseases Pharmacy

Temple University

Philadelphia, Pennsylvania

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Discuss investigational treatments, vaccine trials, and review profession=
al reporting responsibilitiesRecognize the potential utility behind thera=
pies being utilized for COVID-19 and where they may be most usefulReview =
patient monitoring and counseling principles to patients with COVID-19

This activity is supported by an educational grant from Pfizer Inc.

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qtukic-l-x Preferences https:/=
/pharmacytimescontinuingeducation.updatemyprofile.com/j-qtukic-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimescont=
inuingeducation.cmail20.com/t/j-u-qtukic-ttqvtdkr-c/

--_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">

=20
t:400,700,400italic|Open+Sans:400italic,700italic,700,400|Roboto:400,700,=
400italic,700italic" rel=3D"stylesheet" type=3D"text/css">

ize-adjust: 100%;">

eight:0;overflow:hidden;font-size:0;">Accredited COVID-19 Live Webinar Se=
ries‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj; ‌ ‌ ‌ ‌ ‌ &z=
wnj; ‌ ‌ ‌ ‌ ‌ &zw=
nj; ‌ ‌ ‌ ‌ ‌ &zwn=
j; ‌ ‌ ‌ ‌ ‌ &zwnj=
; ‌ ‌ ‌ ‌ ‌ ‌=
‌ ‌ ‌ ‌ ‌ ‌&=
nbsp;‌ ‌ ‌ ‌ ‌ ‌&n=
bsp;‌ ‌ ‌ ‌ ‌ ‌&nb=
sp;‌ ‌ ‌ ‌ ‌ ‌&nbs=
p;‌ ‌ ‌ ‌ ‌ ‌ =
;‌ ‌ ‌ ‌ ‌ ‌ =
‌ ‌ ‌ ‌ ‌ ‌ &=
zwnj;

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">

;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">

00%;">

ft;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 140px; w=
idth: 140px;width: calc(14000% - 78120px);padding: 10px 0 5px 0;color: #4=
d4d4d;font-family: Open Sans,sans-serif;">
=20

left;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 139px=
; width: 139px;width: calc(14100% - 78680px);padding: 10px 0 5px 0;text-a=
lign: right;color: #4d4d4d;font-family: Open Sans,sans-serif;">

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #4d4d4d;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com=
/t/j-e-qtukic-ttqvtdkr-t/">Click here

n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">

x;line-height: 32px;Margin-top: 6px;Margin-bottom: 14px;color: #2f353e;fo=
nt-family: PT Sans,Trebuchet MS,sans-serif;" align=3D"center">

eader">;color: #2f353e;" href=3D"https://pharmacytimescontinuingeducation.cmail2=
0.com/t/j-l-qtukic-ttqvtdkr-r/">ight: auto;width: 100%;border: 0;max-width: 205px;" src=3D"http://i1.cmai=
l20.com/ei/j/8D/C4C/A66/034601/csfinal/AllPTCElogo.png" alt=3D"" width=3D=
"205">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

o-repeat url(http://i1.cmail20.com/ei/j/8D/C4C/A66/034601/csfinal/PTCE_CO=
VID_Email_051320v22.png) #820c0c;background-position: 23% 11%;background-=
image: url(http://i1.cmail20.com/ei/j/8D/C4C/A66/034601/csfinal/PTCE_COVI=
D_Email_051320v22.png);background-repeat: no-repeat;background-size: cove=
r;">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

ize: 1px;">

=20

rtical-align: middle;">

-size: 17px;line-height: 26px;text-align: center;" lang=3D"x-size-18">Par=
t 2 of a 5-Part Live Webinar Series

"Margin-top: 20px;Margin-bottom: 20px;font-size: 18px;line-height: 26px;t=
ext-align: center;" lang=3D"x-size-22">Existing and Investigation=
al Pharmacotherapy for COVID-19

0.75 Live Credit

=20

ize: 1px;">

=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Sunday, May 31 at 12:00 PM ETong>

=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;line-height: 23px;text-align: center;=
">This second webinar in the 5-part serie=
s will delve into the pharmacist’s responsibility to report fr=
audulent products and potential drug shortages. Investigational pharmacot=
herapy information for the care of patients with confirmed COVID-19 will =
be presented.

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qtukic-ttqvtdkr-y/">splay: block;height: auto;width: 100%;max-width: 219px;" alt=3D"" width=3D=
"219" src=3D"http://i1.cmail20.com/ei/j/8D/C4C/A66/034601/csfinal/PTCE_He=
patocellularCarcinoma_Button_070919v11-210a9571ca8829c2.png">

=20

op: 20px;">

ize: 1px;">

=20

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

size: 1px;">

=20

rtical-align: middle;">

<=
strong>Faculty Presenter>

style=3D"color:#080108">Jason C. Gallagher, PharmD, FCCP, FIDP, =
FIDSA, BCPS

Clinical Professor

Clinical Specialist, Infectious Diseases

Director, PGY2 Residency in Infectious Diseases Pharmacy

Temple University

Philadelphia, Pennsylvania

=20

size: 20px;">

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

ize: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

rtical-align: middle;">

-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 16px;line-h=
eight: 24px;text-align: left;" lang=3D"x-size-16">tserrat">Educational Objectivesrong>

Upon completion of this educational activity, participants will be ab=
le to:

20px;Margin-left: 24px;padding: 0;list-style-type: disc;">
argin-top: 20px;Margin-bottom: 0;Margin-left: 0;">Discuss investigational=
treatments, vaccine trials, and review professional reporting responsibi=
lities
R=
ecognize the potential utility behind therapies being utilized for COVID-=
19 and where they may be most useful
n-bottom: 0;Margin-left: 0;">Review patient monitoring and counseling pri=
nciples to patients with COVID-19

=20

mal;line-height: 19px;" align=3D"center">
ease-in;color: #fff;" href=3D"https://pharmacytimescontinuingeducation.c=
mail20.com/t/j-l-qtukic-ttqvtdkr-j/">splay: block;height: auto;width: 100%;max-width: 229px;" alt=3D"" width=3D=
"229" src=3D"http://i2.cmail20.com/ei/j/8D/C4C/A66/034601/csfinal/PTCE_Bl=
ue_LearnMore_071619v11-990b6d028a028a3c.png">

=20

op: 20px;">

rtical-align: middle;">

ont-family: montserrat,dejavu sans,verdana,sans-serif;font-size: 12px;lin=
e-height: 19px;text-align: center;" lang=3D"x-size-12">t-montserrat">This activity is supported by an educational grant from Pfi=
zer Inc.

=20

ize: 1px;">

=20

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

size: 1px;">

=20

ize: 1px;">

=20

mal;line-height: 19px;" align=3D"center">
;max-width: 600px;" alt=3D"" width=3D"600" src=3D"http://i3.cmail20.com/e=
i/j/8D/C4C/A66/034601/csfinal/UpdatedPTCE_Rebrand_EmailBanner_042420v2-99=
00000000079e3c.jpg">

=20

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

ize: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

ize: 1px;">

=20

=20
=20

max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 1674=
00px);overflow-wrap: break-word;word-wrap: break-word;word-break: break-w=
ord;">

;display: table;width: 100%;">

e: 12px;line-height: 19px;color: #4d4d4d;font-family: Open Sans,sans-seri=
f;Float: left;max-width: 400px;min-width: 320px; width: 320px;width: calc=
(8000% - 47600px);">

op: 10px;Margin-bottom: 10px;">
=20

Pharmacy Times Continuing Education™ –=
an MJH Life Sciences brand

Copyright 2020 © Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512

p: 18px;">
=20

ize: 12px;line-height: 19px;color: #4d4d4d;font-family: Open Sans,sans-se=
rif;Float: left;max-width: 320px;min-width: 200px; width: 320px;width: ca=
lc(72200px - 12000%);">

op: 10px;Margin-bottom: 10px;">

=20
=20
=20

exactly;">
0.1s ease-in;color: #ffffff;border-radius: 2px;display: inline-block;fon=
t-size: 11px;font-weight: bold;line-height: 19px;text-align: left;border-=
style: solid;border-width: 4px 7px 3px 4px;mso-border-width-alt: 4px 8px =
8px 8px;background-color: gray;border-color: gray;mso-border-color-alt: g=
ray;" href=3D"https://pharmacytimescontinuingeducation.forwardtomyfriend.=
com/j-ttqvtdkr-EE17CB78-qtukic-l-i" lang=3D"en">
;margin-right: 2px;vertical-align: -3px;" src=3D"http://i2.cmail20.com/st=
atic/eb/master/13-the-blueprint-3/images/forward-icon-at-2x.png" width=3D"16=
" height=3D"16" border=3D"0" alt=3D"">
">Forward

o;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% - 16=
7400px);overflow-wrap: break-word;word-wrap: break-word;word-break: break=
-word;">

;display: table;width: 100%;">

px;line-height: 19px;color: #4d4d4d;font-family: Open Sans,sans-serif;">

op: 10px;Margin-bottom: 10px;">

: opacity 0.1s ease-in;color: #4d4d4d;" href=3D"https://pharmacytimescont=
inuingeducation.updatemyprofile.com/j-qtukic-EE17CB78-=
ttqvtdkr-d" lang=3D"en">Preferences | =
olor: #4d4d4d;" href=3D"https://pharmacytimescontinuingeducation.cmail20.=
com/t/j-u-qtukic-ttqvtdkr-h/">Unsubscribe

rtant;display: block !important;height: 1px !important;width: 1px !import=
ant;border: 0 !important;margin: 0 !important;padding: 0 !important;" src=
=3D"https://pharmacytimescontinuingeducation.cmail20.com/t/j-o-qtukic-=
ttqvtdkr/o.gif" width=3D"1" height=3D"1" border=3D"0" alt=3D"">
=

--_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_--

--===============1122153626==
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit
Content-Disposition: inline

_______________________________________________
Hangout mailing list
Hangout-at-nylxs.com
http://lists.mrbrklyn.com/mailman/listinfo/hangout

--===============1122153626==--

--===============1122153626==
Content-Type: multipart/alternative;
boundary="_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_"; charset=utf-8

--_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_
Content-Type: text/plain;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

No images? Click here https://pharmacytimescontinuingeducation.cmail20.c=
om/t/j-e-qtukic-ttqvtdkr-p/

Part 2 of a 5-Part Live Webinar Series

Existing and Investigational Pharmacotherapy for COVID-19

0.75 Live Credit

Sunday, May 31 at 12:00 PM ET

This second webinar in the 5-part series will delve into the pharmacist=E2=
=80=99s responsibility to report fraudulent products and potential drug s=
hortages. Investigational pharmacotherapy information for the care of pat=
ients with confirmed COVID-19 will be presented.

Faculty Presenter

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Clinical Professor

Clinical Specialist, Infectious Diseases

Director, PGY2 Residency in Infectious Diseases Pharmacy

Temple University

Philadelphia, Pennsylvania

Educational Objectives

Upon completion of this educational activity, participants will be able t=
o:

Discuss investigational treatments, vaccine trials, and review profession=
al reporting responsibilitiesRecognize the potential utility behind thera=
pies being utilized for COVID-19 and where they may be most usefulReview =
patient monitoring and counseling principles to patients with COVID-19

This activity is supported by an educational grant from Pfizer Inc.

Pharmacy Times Continuing Education=E2=84=A2 =E2=80=93 an MJH Life Scienc=
es brand

Copyright 2020 =C2=A9 Pharmacy and Healthcare Communications, LLC

2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512 Forward =
https://pharmacytimescontinuingeducation.forwardtomyfriend.com/j-=
ttqvtdkr-EE17CB78-qtukic-l-x Preferences https:/=
/pharmacytimescontinuingeducation.updatemyprofile.com/j-qtukic-=
EE17CB78-ttqvtdkr-m | Unsubscribe https://pharmacytimescont=
inuingeducation.cmail20.com/t/j-u-qtukic-ttqvtdkr-c/

--_a3ee5e86-6147-4901-8b5b-3dbaaed72be0_
Content-Type: text/html;
charset="utf-8"
Content-Transfer-Encoding: quoted-printable

ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">99/xhtml">
-8">

E=3Dedge">

=20
t:400,700,400italic|Open+Sans:400italic,700italic,700,400|Roboto:400,700,=
400italic,700italic" rel=3D"stylesheet" type=3D"text/css">

ize-adjust: 100%;">

out: fixed;min-width: 320px;width: 100%;background-color: #fff;" cellpadd=
ing=3D"0" cellspacing=3D"0" role=3D"presentation">

;min-width: 280px; width: 280px;width: calc(28000% - 167440px);">

00%;">

ft;font-size: 12px;line-height: 19px;max-width: 280px;min-width: 140px; w=
idth: 140px;width: calc(14000% - 78120px);padding: 10px 0 5px 0;color: #4=
d4d4d;font-family: Open Sans,sans-serif;">
=20

No images? style=3D"text-decoration: underline;transition: opacity 0.1s ease-in;colo=
r: #4d4d4d;" href=3D"https://pharmacytimescontinuingeducation.cmail20.com=
/t/j-e-qtukic-ttqvtdkr-t/">Click here

n-width: 320px; width: 320px;width: calc(28000% - 167400px);" id=3D"emb-e=
mail-header-container">

x;line-height: 32px;Margin-top: 6px;Margin-bottom: 14px;color: #2f353e;fo=
nt-family: PT Sans,Trebuchet MS,sans-serif;" align=3D"center">

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

ize: 1px;">

=20

rtical-align: middle;">

-size: 17px;line-height: 26px;text-align: center;" lang=3D"x-size-18">Par=
t 2 of a 5-Part Live Webinar Series

"Margin-top: 20px;Margin-bottom: 20px;font-size: 18px;line-height: 26px;t=
ext-align: center;" lang=3D"x-size-22">Existing and Investigation=
al Pharmacotherapy for COVID-19

0.75 Live Credit

=20

ize: 1px;">

=20

rtical-align: middle;">

rrat,dejavu sans,verdana,sans-serif;text-align: center;">ont-montserrat">Sunday, May 31 at 12:00 PM ETong>

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

size: 1px;">

=20

rtical-align: middle;">

<=
strong>Faculty Presenter>

=20

size: 20px;">

=20

auto;max-width: 600px;min-width: 320px; width: 320px;width: calc(28000% -=
167400px);overflow-wrap: break-word;word-wrap: break-word;word-break: br=
eak-word;">

isplay: table;width: 100%;background-color: #ffffff;">

t-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">
=20

ize: 1px;">

=20

idth: 600px;min-width: 320px; width: 320px;width: calc(28000% - 167400px)=
;overflow-wrap: break-word;word-wrap: break-word;word-break: break-word;"=
>

;display: table;width: 100%;">

ont-size: 16px;line-height: 24px;font-family: Roboto,Tahoma,sans-serif;">=

=20

size: 1px;">

=20

rtical-align: middle;">